IMPORTANCE OF OXIDATIVE POLYMORPHISM ON CLINICAL EFFICACY AND SIDE-EFFECTS OF IMIPRAMINE - A RETROSPECTIVE STUDY

被引:16
作者
MEYER, JW
WOGGON, B
KUPFER, A
机构
[1] UNIV ZURICH,PSYCHIAT KLIN,DEPT RES,CH-8000 ZURICH,SWITZERLAND
[2] UNIV BERN,INST CLIN PHARMACOL,CH-3010 BERN,SWITZERLAND
关键词
D O I
10.1055/s-2007-1017010
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
引用
收藏
页码:365 / 366
页数:2
相关论文
共 10 条
[1]  
ANGST J, 1969, ARZNEIMITTEL-FORSCH, V19, P339
[2]   THE DEBRISOQUINE HYDROXYLATION TEST PREDICTS STEADY-STATE PLASMA-LEVELS OF DESIPRAMINE [J].
BERTILSSON, L ;
ABERGWISTEDT, A .
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1983, 15 (03) :388-390
[3]  
DICK B, 1982, SCHWEIZ MED WSCHR, V112, P1061
[4]  
GARVEY MJ, 1984, AM J PSYCHIAT, V141, P853
[5]   EFFECTS OF SEVERAL TRICYCLIC ANTIDEPRESSANTS ON HEMODYNAMICS AND MYOCARDIAL-CONTRACTILITY OF ANESTHETIZED DOGS [J].
JANDHYALA, BS ;
STEENBERG, ML ;
PEREL, JM ;
MANIAN, AA ;
BUCKLEY, JP .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1977, 42 (04) :403-410
[6]   PHARMACOGENETICS OF MEPHENYTOIN - A NEW DRUG HYDROXYLATION POLYMORPHISM IN MAN [J].
KUPFER, A ;
PREISIG, R .
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1984, 26 (06) :753-759
[7]   PLASMA-CONCENTRATIONS OF NORTRIPTYLINE AND ITS 10-HYDOXY METABOLITE IN DEPRESSED-PATIENTS RELATIONSHIP TO THE DEBRISOQUINE HYDROXYLATION METABOLIC RATIO [J].
NORDIN, C ;
SIWERS, B ;
BENITEZ, J ;
BERTILSSON, L .
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1985, 19 (06) :832-835
[8]   COMPETITIVE-INHIBITION OF SPARTEINE OXIDATION IN HUMAN-LIVER BY BETA-ADRENOCEPTOR ANTAGONISTS AND OTHER CARDIOVASCULAR DRUGS [J].
OTTON, SV ;
INABA, T ;
KALOW, W .
LIFE SCIENCES, 1984, 34 (01) :73-80
[9]   ACTIVE METABOLITES OF IMIPRAMINE AND DESIPRAMINE IN MAN [J].
POTTER, WZ ;
CALIL, HM ;
SUTFIN, TA ;
ZAVADIL, AP ;
JUSKO, WJ ;
RAPOPORT, J ;
GOODWIN, FK .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 1982, 31 (03) :393-401
[10]  
RUDORFER MV, 1987, PSYCHOPHARMACOLOGY 3, P1353